ARROWSTREET CAPITAL, LIMITED PARTNERSHIP - BIOGEN IDEC INC ownership

BIOGEN IDEC INC's ticker is and the CUSIP is 09062X10. A total of 1 filers reported holding BIOGEN IDEC INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ownership history of BIOGEN IDEC INC
ValueSharesWeighting
Q4 2015$88,613,000
-70.4%
289,253
-68.2%
0.41%
-47.2%
Q3 2015$299,489,000
+144.8%
909,920
+200.4%
0.77%
+11.6%
Q2 2015$122,357,000
+13694.5%
302,910
+14324.3%
0.69%
+13740.0%
Q1 2015$887,000
-99.2%
2,100
-99.4%
0.01%
-99.2%
Q3 2014$110,098,000
+38.6%
332,814
+32.1%
0.59%
+44.9%
Q2 2014$79,427,000
-61.2%
251,901
-62.4%
0.41%
-67.1%
Q1 2014$204,966,000
+5.9%
670,109
-3.1%
1.24%
+18.3%
Q4 2013$193,462,000
+17.4%
691,554
+1.1%
1.05%
+0.1%
Q3 2013$164,721,000
+23.9%
684,173
+10.7%
1.05%
+5.7%
Q2 2013$132,944,000617,7690.99%
Other shareholders
BIOGEN IDEC INC shareholders Q1 2015
NameSharesValueWeighting ↓
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 909,920$299,489,0000.77%
CenterStar Fund, LLC 1,468$408,0000.28%
CenterStar Fund, LLC 100$118,0000.08%
INGALLS & SNYDER LLC 2,123$619,0000.04%
View complete list of BIOGEN IDEC INC shareholders